Abedin SM - Search Results

1

Identification and targeting of novel CDK9 complexes in acute myeloid leukemia.

Beauchamp EM, Abedin SM, Radecki SG, Fischietti M, Arslan AD, Blyth GT, Yang A, Lantz C, Nelson A, Goo YA, Akpan I, Eklund EA, Frankfurt O, Fish EN, Thomas PM, Altman JK, Platanias LC. Beauchamp EM, et al. Among authors: abedin sm. Blood. 2019 Mar 14;133(11):1171-1185. doi: 10.1182/blood-2018-08-870089. Epub 2018 Dec 26. Blood. 2019. PMID: 30587525 Free PMC article.

2

Whole-exome sequencing for relapse prediction in patients discontinuing TKI treatment in chronic myeloid leukemia.

Abedin S, Platanias LC. Abedin S, et al. Leuk Lymphoma. 2016 Jul;57(7):1503-4. doi: 10.3109/10428194.2016.1151514. Epub 2016 Feb 25. Leuk Lymphoma. 2016. PMID: 26915266 No abstract available.

3

Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.

Kosciuczuk EM, Saleiro D, Kroczynska B, Beauchamp EM, Eckerdt F, Blyth GT, Abedin SM, Giles FJ, Altman JK, Platanias LC. Kosciuczuk EM, et al. Among authors: abedin sm. Blood. 2016 Jul 21;128(3):410-4. doi: 10.1182/blood-2016-02-698704. Epub 2016 Jun 15. Blood. 2016. PMID: 27307295 Free PMC article.

4

PD1 and PDL1 upregulation and survival after decitabine treatment in lower risk MDS.

Abedin S, Platanias LC. Abedin S, et al. Leuk Lymphoma. 2017 Apr;58(4):764-765. doi: 10.1080/10428194.2016.1251594. Epub 2016 Nov 3. Leuk Lymphoma. 2017. PMID: 27808592 No abstract available.

5

Acute promyelocytic leukemia: preventing early complications and late toxicities.

Abedin S, Altman JK. Abedin S, et al. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):10-15. doi: 10.1182/asheducation-2016.1.10. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913456 Free PMC article. Review.

6

Circulating microRNAs: promising biomarkers in aplastic anemia.

Bell JB, Abedin S, Platanias LC. Bell JB, et al. Haematologica. 2017 Jan;102(1):1-2. doi: 10.3324/haematol.2016.156117. Haematologica. 2017. PMID: 28040785 Free PMC article. No abstract available.

7

Implications of high EVI1 expression in high-risk myelodysplastic syndromes.

Abedin S, Platanias LC. Abedin S, et al. Leuk Lymphoma. 2018 Dec;59(12):2765-2766. doi: 10.1080/10428194.2018.1466297. Epub 2018 May 2. Leuk Lymphoma. 2018. PMID: 29718736 No abstract available.

8

Natural killer cell activity and survival after azacitidine treatment in high-risk MDS.

Abedin SM, Platanias LC. Abedin SM, et al. Leuk Lymphoma. 2019 Oct;60(10):2343-2344. doi: 10.1080/10428194.2019.1613543. Epub 2019 May 23. Leuk Lymphoma. 2019. PMID: 31120354 No abstract available.

9

Inhibitory effects of SEL201 in acute myeloid leukemia.

Kosciuczuk EM, Kar AK, Blyth GT, Fischietti M, Abedin S, Mina AA, Siliezar R, Rzymski T, Brzozka K, Eklund EA, Beauchamp EM, Eckerdt F, Saleiro D, Platanias LC. Kosciuczuk EM, et al. Oncotarget. 2019 Dec 24;10(67):7112-7121. doi: 10.18632/oncotarget.27388. eCollection 2019 Dec 24. Oncotarget. 2019. PMID: 31903169 Free PMC article.

10

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies.

Davids MS, Brander DM, Alvarado Valero Y, Diefenbach CS, Egan DN, Dinner SN, Javidi-Sharifi N, Al Malki MM, Begna K, Bhatt VR, Abedin S, Cook R, Collins MC, Roleder C, Dominguez EC, Rajagopalan P, Wiley SE, Ghalie RG, Danilov AV. Davids MS, et al. Blood Adv. 2024 Dec 20:bloodadvances.2024014633. doi: 10.1182/bloodadvances.2024014633. Online ahead of print. Blood Adv. 2024. PMID: 39705540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters